secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-05-14T01:08:16+00:00
Accession:  0001493152-26-022823
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Q3 revenue $1.06M (+46% YoY); cartridge sales up 59%
--------------------------------------------------------------------

- Q3 cartridge revenue $703,538, up 59% YoY, representing 66% of total sales.
- Gross profit margin expanded to 50.5% in Q3 (vs 46.8% prior year); nine-month margin 49.3%.
- Nine-month revenue reached $3.07M, up 39% YoY; cash balance $6.86M at March 31, 2026.
- Marketing spend in Q3 down 42% YoY while commercial momentum accelerated.
- FDA 510(k) program advancing; new manufacturing partnership and Bouygues UK customer added.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226022823/0001493152-26-022823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226022823/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-022823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer